{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:28:46Z","timestamp":1793672926973,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00347-023-01960-z","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T15:02:20Z","timestamp":1702393340000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HLA-B27-positive anterior uveitis","HLA-B27-positive Uveitis anterior"],"prefix":"10.1007","volume":"121","author":[{"given":"Peter","family":"Werkl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"3","key":"1960_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs\u00a0DA, Nussenblatt\u00a0RB, Rosenbaum\u00a0JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1960_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00347-019-01028-x","volume":"117","author":"M Lenglinger","year":"2020","unstructured":"Lenglinger\u00a0M, Pohlmann\u00a0D, Pleyer\u00a0U (2020) Anteriore virale Uveitis. Klinik, diagnostisches Vorgehen und Behandlungsoptionen. Ophthalmologe 117(1):83\u201392","journal-title":"Ophthalmologe"},{"issue":"4","key":"1960_CR3","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","volume":"15","author":"B Chen","year":"2017","unstructured":"Chen\u00a0B, Li\u00a0J, He\u00a0C, Li\u00a0D, Tong\u00a0W, Zou\u00a0Y et al (2017) Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review). Mol Med Rep 15(4):1943\u20131951","journal-title":"Mol Med Rep"},{"key":"1960_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/art.42315","author":"J Rademacher","year":"2022","unstructured":"Rademacher\u00a0J, Mullner\u00a0H, Diekhoff\u00a0T, Haibel\u00a0H, Igel\u00a0S, Pohlmann\u00a0D et\u00a0al (2022) Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.42315","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1960_CR5","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/09273948.2016.1175641","volume":"24","author":"CH Sibley","year":"2016","unstructured":"Sibley\u00a0CH (2016) Autoinflammation and HLA-B27: beyond antigen presentation. Ocul Immunol Inflamm 24(4):460\u2013469","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"1960_CR6","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1186\/ar4341","volume":"15","author":"RL Roberts","year":"2013","unstructured":"Roberts\u00a0RL, Wallace\u00a0MC, Jones\u00a0GT, van Rij\u00a0AM, Merriman\u00a0TR, Harrison\u00a0A et al (2013) Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity. Arthritis Res Ther 15(5):R158","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1960_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1185527","volume":"25","author":"K Pathanapitoon","year":"2017","unstructured":"Pathanapitoon\u00a0K, Dodds\u00a0EM, Cunningham\u00a0ET Jr., Rothova\u00a0A (2017) Clinical spectrum of HLA-B27-associated ocular inflammation. Ocul Immunol Inflamm 25(4):569\u2013576","journal-title":"Ocul Immunol Inflamm"},{"key":"1960_CR8","doi-asserted-by":"publisher","first-page":"608134","DOI":"10.3389\/fimmu.2020.608134","volume":"11","author":"D Wakefield","year":"2020","unstructured":"Wakefield\u00a0D, Clarke\u00a0D, McCluskey\u00a0P (2020) Recent developments in HLA B27 anterior uveitis. Front Immunol 11:608134","journal-title":"Front Immunol"},{"issue":"12","key":"1960_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41584-018-0097-2","volume":"14","author":"JT Rosenbaum","year":"2018","unstructured":"Rosenbaum\u00a0JT, Asquith\u00a0M (2018) The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol 14(12):704\u2013713","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"1960_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0002-9394(14)74218-7","volume":"103","author":"A Rothova","year":"1987","unstructured":"Rothova\u00a0A, van Veenedaal\u00a0WG, Linssen\u00a0A, Glasius\u00a0E, Kijlstra\u00a0A, de Jong\u00a0PT (1987) Clinical features of acute anterior uveitis. Am J Ophthalmol 103(2):137\u2013145","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1960_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ajo.2007.11.009","volume":"145","author":"AM Braakenburg","year":"2008","unstructured":"Braakenburg\u00a0AM, de Valk\u00a0HW, de Boer\u00a0J, Rothova\u00a0A (2008) Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol 145(3):472\u2013479","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1960_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","volume":"50","author":"JH Chang","year":"2005","unstructured":"Chang\u00a0JH, McCluskey\u00a0PJ, Wakefield\u00a0D (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50(4):364\u2013388","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"1960_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper\u00a0J, van der Heijde\u00a0D, Landewe\u00a0R, Brandt\u00a0J, Burgos-Vagas\u00a0R, Collantes-Estevez\u00a0E et al (2009) New criteria for inflammatory back pain in patients with chronic back pain: a\u00a0real patient exercise by experts from the assessment of spondyloarthritis international society (ASAS). Ann Rheum Dis 68(6):784\u2013788","journal-title":"Ann Rheum Dis"},{"issue":"10089","key":"1960_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"J Sieper","year":"2017","unstructured":"Sieper\u00a0J, Poddubnyy\u00a0D (2017) Axial spondyloarthritis. Lancet 390(10089):73\u201384","journal-title":"Lancet"},{"issue":"3","key":"1960_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.berh.2019.02.010","volume":"32","author":"A Molto","year":"2018","unstructured":"Molto\u00a0A, Sieper\u00a0J (2018) Peripheral spondyloarthritis: concept, diagnosis and treatment. Best Pract Res Clin Rheumatol 32(3):357\u2013368","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"1960_CR16","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","volume":"95","author":"MN Magrey","year":"2020","unstructured":"Magrey\u00a0MN, Danve\u00a0AS, Ermann\u00a0J, Walsh\u00a0JA (2020) Recognizing axial spondyloarthritis: a guide for primary care. Mayo Clin Proc 95(11):2499\u20132508","journal-title":"Mayo Clin Proc"},{"issue":"10080","key":"1960_CR17","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres\u00a0J, Mehandru\u00a0S, Colombel\u00a0JF, Peyrin-Biroulet\u00a0L (2017) Crohn\u2019s disease. Lancet 389(10080):1741\u20131755","journal-title":"Lancet"},{"issue":"10080","key":"1960_CR18","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro\u00a0R, Mehandru\u00a0S, Allen\u00a0PB, Peyrin-Biroulet\u00a0L, Colombel\u00a0JF (2017) Ulcerative colitis. Lancet 389(10080):1756\u20131770","journal-title":"Lancet"},{"issue":"4","key":"1960_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler\u00a0G, Singh\u00a0A, Kavanaugh\u00a0A, Rubin\u00a0DT (2021) Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology 161(4):1118\u20131132","journal-title":"Gastroenterology"},{"issue":"32","key":"1960_CR20","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","volume":"23","author":"LL Troncoso","year":"2017","unstructured":"Troncoso\u00a0LL, Biancardi\u00a0AL, de Moraes\u00a0HV Jr., Zaltman\u00a0C (2017) Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol 23(32):5836\u20135848","journal-title":"World J Gastroenterol"},{"key":"1960_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/978-3-662-60399-4_24","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"J Rademacher","year":"2021","unstructured":"Rademacher\u00a0J, Pleyer\u00a0U, Winterhalter\u00a0S (2021) Spondylarthritis. In: Pleyer\u00a0U (ed) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin, Heidelberg, pp\u00a0503\u2013517"},{"issue":"1","key":"1960_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit\u00a0M, van der Heijde\u00a0D, Landewe\u00a0R, Akkoc\u00a0N, Brandt\u00a0J, Chou\u00a0CT et\u00a0al (2011) The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25\u201331","journal-title":"Ann Rheum Dis"},{"key":"1960_CR23","unstructured":"Deutsche Ophthalmologische Gesellschaft e.\u202fV. (2010) Leitlinie Nr.\u00a014a Uveitis anterior. https:\/\/www.dog.org\/wp-content\/uploads\/2009\/09\/LL-Uveitis-anterior-2011-08-03-Endversion.pdf. Zugegriffen: 7. Okt. 2022"},{"issue":"5","key":"1960_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/1120672119856943","volume":"30","author":"A Bernard","year":"2020","unstructured":"Bernard\u00a0A, Seve\u00a0P, Abukhashabh\u00a0A, Roure-Sobas\u00a0C, Boibieux\u00a0A, Denis\u00a0P et al (2020) Lyme-associated uveitis: clinical spectrum and review of literature. Eur J Ophthalmol 30(5):874\u2013885","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"1960_CR25","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.autrev.2017.10.010","volume":"16","author":"P Seve","year":"2017","unstructured":"Seve\u00a0P, Cacoub\u00a0P, Bodaghi\u00a0B, Trad\u00a0S, Sellam\u00a0J, Bellocq\u00a0D et al (2017) Uveitis: diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev 16(12):1254\u20131264","journal-title":"Autoimmun Rev"},{"key":"1960_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/978-3-662-60399-4_22","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"U Pleyer","year":"2021","unstructured":"Pleyer\u00a0U, Quentin\u00a0CD (2021) Virale anteriore Uveitis. In: Pleyer\u00a0U (ed) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin, Heidelberg, pp\u00a0475\u2013487"},{"issue":"11","key":"1960_CR27","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon\u00a0M, O\u2019Rourke\u00a0M, Ramasamy\u00a0P, Murphy\u00a0CC, FitzGerald\u00a0O (2015) A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 74(11):1990\u20131995","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1960_CR28","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","volume":"74","author":"D Poddubnyy","year":"2015","unstructured":"Poddubnyy\u00a0D, van Tubergen\u00a0A, Landew\u00e9\u00a0R, Sieper\u00a0J, van der Heijde\u00a0D (2015) Development of an ASAS-endorsed recommendation for the early referral of patients with a\u00a0suspicion of axial spondyloarthritis. Ann Rheum Dis 74(8):1483\u20131487","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1960_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00393-011-0892-5","volume":"71","author":"D Poddubnyy","year":"2012","unstructured":"Poddubnyy\u00a0D, Rudwaleit\u00a0M, Sieper\u00a0J (2012) Fr\u00fche Spondyloarthritiden, Diagnostisches Vorgehen und Screening. Z\u00a0Rheumatol 71(1):19\u201326","journal-title":"Z Rheumatol"},{"issue":"5","key":"1960_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1055\/s-0043-105139","volume":"234","author":"A Heiligenhaus","year":"2017","unstructured":"Heiligenhaus\u00a0A, Kasper\u00a0M, Grajewski\u00a0R (2017) HLA-B27 positive acute anterior uveitis. Klin Monbl Augenheilkd 234(5):652\u2013656","journal-title":"Klin Monbl Augenheilkd"},{"key":"1960_CR31","doi-asserted-by":"publisher","first-page":"1759720X2095173","DOI":"10.1177\/1759720X20951733","volume":"12","author":"J Rademacher","year":"2020","unstructured":"Rademacher\u00a0J, Poddubnyy\u00a0D, Pleyer\u00a0U (2020) Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20951733","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"10","key":"1960_CR32","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00417-018-4082-x","volume":"256","author":"MM Zu Hoerste","year":"2018","unstructured":"Zu Hoerste\u00a0MM, Walscheid\u00a0K, Tappeiner\u00a0C, Zurek-Imhoff\u00a0B, Heinz\u00a0C, Heiligenhaus\u00a0A (2018) The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a\u00a0retrospective cohort study. Graefes Arch Clin Exp Ophthalmol 256(10):1985\u20131992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1960_CR33","doi-asserted-by":"publisher","first-page":"e0230560","DOI":"10.1371\/journal.pone.0230560","volume":"15","author":"N Bouzid","year":"2020","unstructured":"Bouzid\u00a0N, Jamilloux\u00a0Y, Chapurlat\u00a0R, Pradat\u00a0P, De Parisot\u00a0A, Kodjikian\u00a0L et al (2020) Impact of systemic treatments on the course of HLA-B27-associated uveitis: a retrospective study of 101\u00a0patients. PLoS ONE 15(3):e230560","journal-title":"PLoS ONE"},{"issue":"4","key":"1960_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/09273940802204519","volume":"16","author":"PA Pacheco","year":"2008","unstructured":"Pacheco\u00a0PA, Taylor\u00a0SR, Cuchacovich\u00a0MT, Diaz\u00a0GV (2008) Azathioprine in the management of autoimmune uveitis. Ocul Immunol Inflamm 16(4):161\u2013165","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"1960_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe\u00a0GJ, Dick\u00a0AD, Brezin\u00a0AP, Nguyen\u00a0QD, Thorne\u00a0JE, Kestelyn\u00a0P et\u00a0al (2016) Adalimumab in patients with active noninfectious uveitis. N\u00a0Engl J Med 375(10):932\u2013943","journal-title":"N Engl J Med"},{"issue":"10050","key":"1960_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen\u00a0QD, Merrill\u00a0PT, Jaffe\u00a0GJ, Dick\u00a0AD, Kurup\u00a0SK, Sheppard\u00a0J et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a\u00a0multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388(10050):1183\u20131192","journal-title":"Lancet"},{"issue":"17","key":"1960_CR37","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","volume":"376","author":"AV Ramanan","year":"2017","unstructured":"Ramanan\u00a0AV, Dick\u00a0AD, Jones\u00a0AP, McKay\u00a0A, Williamson\u00a0PR, Compeyrot-Lacassagne\u00a0S et al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N\u00a0Engl J Med 376(17):1637\u20131646","journal-title":"N Engl J Med"},{"issue":"5","key":"1960_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit\u00a0M, Rodevand\u00a0E, Holck\u00a0P, Vanhoof\u00a0J, Kron\u00a0M, Kary\u00a0S et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a\u00a0prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1960_CR39","doi-asserted-by":"publisher","first-page":"e001161","DOI":"10.1136\/rmdopen-2019-001161","volume":"6","author":"I van der Horst-Bruinsma","year":"2020","unstructured":"van der Horst-Bruinsma\u00a0I, van Bentum\u00a0R, Verbraak\u00a0FD, Rath\u00a0T, Rosenbaum\u00a0JT, Misterska-Skora\u00a0M et al (2020) The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C\u2011View. RMD Open 6(1):e1161. https:\/\/doi.org\/10.1136\/rmdopen-2019-001161","journal-title":"RMD Open"},{"issue":"2","key":"1960_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3899\/jrheum.180312","volume":"46","author":"RE van Bentum","year":"2019","unstructured":"van Bentum\u00a0RE, Heslinga\u00a0SC, Nurmohamed\u00a0MT, Gerards\u00a0AH, Griep\u00a0EN, Koehorst\u00a0C et al (2019) Reduced occurrence rate of acute anterior uveitis in ankylosing spondylitis treated with golimumab\u2014the go-easy study. J\u00a0Rheumatol 46(2):153\u2013159","journal-title":"J Rheumatol"},{"issue":"9","key":"1960_CR41","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","volume":"76","author":"E Lie","year":"2017","unstructured":"Lie\u00a0E, Lindstrom\u00a0U, Zverkova-Sandstrom\u00a0T, Olsen\u00a0IC, Forsblad-d\u2019Elia\u00a0H, Askling\u00a0J et al (2017) Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register. Ann Rheum Dis 76(9):1515\u20131521","journal-title":"Ann Rheum Dis"},{"key":"1960_CR42","unstructured":"DGRh (2019) Therapie mit Adalimumab. https:\/\/dgrh.de\/dam\/jcr:f0c50d32-101a-4905-99d2-87c816e2becf\/Adalimumab%20ARZT%2011_2019.pdf. Zugegriffen: 19. Aug. 2022"},{"issue":"5","key":"1960_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1055\/a-1741-8104","volume":"239","author":"Y El-Shabrawi","year":"2022","unstructured":"El-Shabrawi\u00a0Y, Rath\u00a0T, Heiligenhaus\u00a0A (2022) Janus Kinase inhibitors: next-generation treatment for uveitis. Klin Monbl Augenheilkd 239(5):695\u2013701","journal-title":"Klin Monbl Augenheilkd"},{"issue":"5","key":"1960_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr2.11139","volume":"2","author":"AA Deodhar","year":"2020","unstructured":"Deodhar\u00a0AA, Miceli-Richard\u00a0C, Baraliakos\u00a0X, Marzo-Ortega\u00a0H, Gladman\u00a0DD, Blanco\u00a0R et al (2020) Incidence of uveitis in secukinumab-treated patients with ankylosing spondylitis: pooled data analysis from three phase 3 studies. ACR Open Rheumatol 2(5):294\u2013299","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"1960_CR45","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","volume":"122","author":"E Letko","year":"2015","unstructured":"Letko\u00a0E, Yeh\u00a0S, Foster\u00a0CS, Pleyer\u00a0U, Brigell\u00a0M, Grosskreutz\u00a0CL (2015) Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy. Ophthalmology 122(5):939\u2013948","journal-title":"Ophthalmology"},{"issue":"4","key":"1960_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","volume":"120","author":"AD Dick","year":"2013","unstructured":"Dick\u00a0AD, Tugal-Tutkun\u00a0I, Foster\u00a0S, Zierhut\u00a0M, Melissa Liew\u00a0SH, Bezlyak\u00a0V et al (2013) Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology 120(4):777\u2013787","journal-title":"Ophthalmology"},{"issue":"4","key":"1960_CR47","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3346\/jkms.2009.24.4.722","volume":"24","author":"SC Park","year":"2009","unstructured":"Park\u00a0SC, Ham\u00a0DI (2009) Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a\u00a0Korean population. J\u00a0Korean Med Sci 24(4):722\u2013728","journal-title":"J Korean Med Sci"},{"issue":"4","key":"1960_CR48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ajo.2010.04.031","volume":"150","author":"AR Loh","year":"2010","unstructured":"Loh\u00a0AR, Acharya\u00a0NR (2010) Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 150(4):534\u201342.e2","journal-title":"Am J Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01960-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T12:04:26Z","timestamp":1706875466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01960-z"}},"subtitle":["Clinical aspects, diagnostics, interdisciplinary management, and treatment","Klinik, Diagnostik, interdisziplin\u00e4res Management und Therapie. Englische Version"],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":48,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01960-z","relation":{"is-translation-of":[{"id-type":"doi","id":"10.1007\/s00347-022-01793-2","asserted-by":"subject"}]},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"8 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"In accordance with Springer Medicine guidelines, authors and scientific directors are requested to make a\u00a0full declaration of their financial and non-financial interests as part of the manuscript preparation and manuscript approval process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"<b>P.\u00a0Werkl: <\/b>A.\u00a0Financial interests: P.\u00a0Werkl declares no financial conflict of interest.\u2014B.\u00a0Non-financial interests: resident in special specialty training at the University Eye Hospital Graz\u2014LKH-Universit\u00e4tsklinikum Graz. <b>J.\u00a0Rademacher: <\/b>A.\u00a0Financial interests: congress attendance reimbursement: Novartis, UCB, AbbVie.\u2014B.\u00a0Non-financial interests: employed specialist in internal medicine, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Medical Clinic for Gastroenterology, Infectiology and Rheumatology; clinician scientist, BIH Berlin Institute of Health | Memberships: DGRh, DGfI, DGIM, ASAS. <b>U.\u00a0Pleyer: <\/b>A.\u00a0Financial interests: research funding: German Research Foundation, BMBF, European Union; speaker\u2019s fees\/travel reimbursement as passive participant: AbbVie, Alcon, Allergan, Alimera, Bausch and Lomb, Bayer, Novartis, Santen, Thea; I, my spouse\/partner or child(ren) hold patent\/share\/stock or similar in a\u00a0company active in the field of medicine: Bayer, Biontech (shares)\u2014B.\u00a0Non-financial interests: senior physician, Department of Ophthalmology, Charit\u00e9 Universit\u00e4tsmedizin Berlin | Membership\/function in Interest Groups: speaker of the section Uveitis\/DOG since 2014\u00a0| Focus of scientific clinical activities: head of the consulting hours \u201cTertiary Center for Inflammatory Eye Diseases\u201d from 1994 up to today | Secretary: Berlin-Brandenburg Ophthalmologists | Board member: German UVEITIS Working Group DUAG e.\u202fV. U.\u00a0Pleyer is a\u00a0member of the editorial board of <i>Die Ophthalmologie<\/i>. He was not involved in the review of this manuscript or in any decisions related to this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors"}},{"value":"The full conflict of interest statement for the scientific director can be found at the certified continuing education course at .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Scientific director"}},{"value":"declares that no sponsorship money will be paid to the publisher for the publication of this CME continuing education course.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"The publisher"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were conducted in accordance with the ethical standards indicated in each case. Written consent has been obtained from patients and\/or their legal representatives for images or other information within the manuscript by which patients can be identified.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"The publisher"}},{"value":"The supplement containing this article is not sponsored by industry.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"The publisher"}}]}}